Related Experiment Video
Updated: Jan 9, 2026

Author Spotlight: Implementation of BIVA for Analyzing Disease Risk Factors in Patients with Low Body Cell Mass
Published on: July 14, 2023
Wearable devices detect physiological changes that precede and are associated with symptomatic and inflammatory
Pragya Sharma1, Matteo Danieletto1,2, Jessica K Whang3
1Windreich Department of Artificial Intelligence and Human Health, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Abstract:
Physiological parameters are altered in rheumatoid arthritis (RA). We evaluated whether changes in physiological metrics, collected from wearable devices, identify and precede the development of both symptomatic and inflammatory RA flares. Participants with RA answered daily disease activity surveys and provided laboratory assessments of inflammatory activity. They wore an Apple Watch (n = 35), Fitbit (n = 17), or Oura Ring (n = 3) collecting heart rate (HR), resting heart rate (RHR), heart rate variability (HRV), and steps. Linear mixed effect models were used to associate HR, RHR and steps with flare and remission periods. Cosinor mixed effect models assessed circadian features of HRV. Mixed effect logistic regression models evaluated changes in physiological metrics prior to the onset of flares. The study enrolled 53 participants (88.7% female) with a mean age of 51.1 (SD 15.2) years. Each contributed a mean of 105 (SD 97) days of data. Mean steps were lower, while mean nighttime HR was higher during symptomatic periods, compared to periods of symptomatic remission. Means daily HR, daytime HR, nighttime HR, and RHR were higher during periods of inflammatory flares, compared to inflammatory remission. Circadian features of HRV differentiated inflammatory and symptomatic flares from remission. All metrics were altered up to 4 weeks prior to inflammatory and symptomatic flare development. This suggests the potential use of wearable devices for disease monitoring and flare prediction.
More Related Videos
Related Concept Videos
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Rheumatic Heart Disease IV: Nursing Management
Rheumatic Heart Disease I: Introduction
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Rheumatic Heart Disease III: Medical Management
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

